{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:55:13Z","timestamp":1787504113262,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017268","name":"Berlin Institute of Health","doi-asserted-by":"publisher","award":["2022"],"award-info":[{"award-number":["2022"]}],"id":[{"id":"10.13039\/501100017268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejca.2025.116189","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T16:36:02Z","timestamp":1765989362000},"page":"116189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The basis for future personalized therapy approaches \u2013 Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pancreatic cancer patients"],"prefix":"10.1016","volume":"234","author":[{"given":"Fran\u00e7ois","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1788-6605","authenticated-orcid":false,"given":"Haotian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9213-2737","authenticated-orcid":false,"given":"Uwe","family":"Pelzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Compton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7008-1238","authenticated-orcid":false,"given":"Gregor","family":"Duwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5550-3516","authenticated-orcid":false,"given":"Mihnea P.","family":"Dragomir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Hilfenhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Vecchione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3922-3450","authenticated-orcid":false,"given":"Annabel","family":"Alig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3146-8717","authenticated-orcid":false,"given":"Matth\u00e4us","family":"Felsenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Lerchbaumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0027-7977","authenticated-orcid":false,"given":"Damian T.","family":"Rieke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Bahra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Kutsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7637-4082","authenticated-orcid":false,"given":"Kristina","family":"Tschulik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3297-5801","authenticated-orcid":false,"given":"Sebastian","family":"Stintzing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Keilholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9009-8678","authenticated-orcid":false,"given":"Christopher C.M.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejca.2025.116189_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of pancreatic cancer: global trends, etiology and risk factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"issue":"43","key":"10.1016\/j.ejca.2025.116189_bib2","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.3748\/wjg.v24.i43.4846","article-title":"Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes","volume":"24","author":"McGuigan","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"14","key":"10.1016\/j.ejca.2025.116189_bib3","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.2013.279201","article-title":"Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial","volume":"310","author":"Oettle","year":"2013","journal-title":"Jama"},{"issue":"19","key":"10.1016\/j.ejca.2025.116189_bib4","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.ejca.2025.116189_bib5","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer","volume":"379","author":"Conroy","year":"2018","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.ejca.2025.116189_bib6","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med"},{"issue":"10409","key":"10.1016\/j.ejca.2025.116189_bib7","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0140-6736(23)01366-1","article-title":"NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial","volume":"402","author":"Wainberg","year":"2023","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ejca.2025.116189_bib8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jamasurg.2021.0149","article-title":"Clinical trials of systemic chemotherapy for resectable pancreatic cancer: a review","volume":"156","author":"Mavros","year":"2021","journal-title":"JAMA Surg"},{"issue":"9","key":"10.1016\/j.ejca.2025.116189_bib9","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jamasurg.2020.2286","article-title":"Response and survival associated with first-line folfirinox vs gemcitabine and nab-paclitaxel chemotherapy for localized pancreatic ductal adenocarcinoma","volume":"155","author":"Perri","year":"2020","journal-title":"JAMA Surg"},{"issue":"12","key":"10.1016\/j.ejca.2025.116189_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7398","article-title":"Challenges and perspectives in use of artificial intelligence to support treatment recommendations in clinical oncology","volume":"13","author":"Duwe","year":"2024","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.ejca.2025.116189_bib11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41591-023-02332-5","article-title":"A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories","volume":"29","author":"Placido","year":"2023","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ejca.2025.116189_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11050606","article-title":"Use of machine-learning algorithms in intensified preoperative therapy of pancreatic cancer to predict individual risk of relapse","volume":"11","author":"Sala Elarre","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2025.116189_bib13","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80150","article-title":"Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer","volume":"11","author":"Wang","year":"2022","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.ejca.2025.116189_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100555","article-title":"Multimodal survival prediction in advanced pancreatic cancer using machine learning","volume":"7","author":"Keyl","year":"2022","journal-title":"ESMO Open"},{"issue":"18","key":"10.1016\/j.ejca.2025.116189_bib15","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1001\/jama.2015.15281","article-title":"Multiple imputation: a flexible tool for handling missing data","volume":"314","author":"Li","year":"2015","journal-title":"Jama"},{"key":"10.1016\/j.ejca.2025.116189_bib16","unstructured":"Microsoft. INDEX and MATCH functions in Excel 2023 [Available from: \u3008https:\/\/support.microsoft.com\/en-us\/excel\u3009."},{"issue":"14","key":"10.1016\/j.ejca.2025.116189_bib17","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJMra1814259","article-title":"Machine learning in medicine","volume":"380","author":"Rajkomar","year":"2019","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ejca.2025.116189_bib18","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1038\/s41416-022-01752-3","article-title":"Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study","volume":"126","author":"Cabasag","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2025.116189_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.106050","article-title":"Usefulness of artificial intelligence for predicting recurrence following surgery for pancreatic cancer: retrospective cohort study","volume":"93","author":"Lee","year":"2021","journal-title":"Int J Surg"},{"issue":"1","key":"10.1016\/j.ejca.2025.116189_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76025-1","article-title":"Prediction of survival and recurrence in patients with pancreatic cancer by integrating multi-omics data","volume":"10","author":"Baek","year":"2020","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.ejca.2025.116189_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082367","article-title":"Inflammation-based prognostic scores in pancreatic cancer patients-a single-center analysis of 1294 patients within the last decade","volume":"15","author":"Neumann","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2025.116189_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s11658-020-00228-7","article-title":"The usefulness of lactate dehydrogenase measurements in current oncological practice","volume":"25","author":"Forkasiewicz","year":"2020","journal-title":"Cell Mol Biol Lett"},{"issue":"4","key":"10.1016\/j.ejca.2025.116189_bib23","article-title":"Low carbohydrate antigen 19-9 (CA 19-9) levels in a patient highly suspected of having caput pancreas tumor","volume":"14","author":"Yong","year":"2022","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.ejca.2025.116189_bib24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41571-022-00686-2","article-title":"The multiple roles of LDH in cancer","volume":"19","author":"Claps","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2025.116189_bib25","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s13277-013-0679-1","article-title":"Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells","volume":"34","author":"Rong","year":"2013","journal-title":"Tumour Biol"},{"issue":"1","key":"10.1016\/j.ejca.2025.116189_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12957-022-02678-z","article-title":"Effects of body mass index and serum albumin on overall survival in patients with cancer undergoing pancreaticoduodenectomy: a single-center retrospective cohort study","volume":"20","author":"Cui","year":"2022","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2025.116189_bib27","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1186\/s12885-021-09056-0","article-title":"Higher body mass index indicated better overall survival in pancreatic ductal adenocarcinoma patients: a real-world study of 2010 patients","volume":"21","author":"Fu","year":"2021","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.ejca.2025.116189_bib28","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.ejrad.2014.04.026","article-title":"Staging accuracy of pancreatic cancer: comparison between non-contrast-enhanced and contrast-enhanced PET\/CT","volume":"83","author":"Yoneyama","year":"2014","journal-title":"Eur J Radio"},{"issue":"12","key":"10.1016\/j.ejca.2025.116189_bib29","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1080\/0284186X.2018.1518593","article-title":"Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis","volume":"57","author":"van Erning","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2025.116189_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejca.2018.10.008","article-title":"Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: a population-based analysis","volume":"106","author":"Mackay","year":"2019","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2025.116189_bib31","doi-asserted-by":"crossref","first-page":"480","DOI":"10.21037\/gs-23-465","article-title":"Increased risk of multiple metastases and worse overall survival of metastatic pancreatic body and tail cancer: a retrospective cohort study","volume":"13","author":"Zhang","year":"2024","journal-title":"Gland Surg"},{"issue":"1","key":"10.1016\/j.ejca.2025.116189_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40425-019-0549-5","article-title":"Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?","volume":"7","author":"M\u00e9n\u00e9trier-Caux","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2025.116189_bib33","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3390\/cells9040855","article-title":"Platelet-leukocyte interplay in cancer development and progression","volume":"9","author":"Stoiber","year":"2020","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.ejca.2025.116189_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018175","article-title":"Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy","volume":"7","author":"Ge","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejca.2025.116189_bib35","doi-asserted-by":"crossref","unstructured":"Ohba A. ea, editor \"Nab-paclitaxel plus gemcitabine versus modified FOLFIRINOX or S-IROX in metastatic or recurrent pancreatic cancer (JCOG1611, GENERATE): a multicenter, randomized, open-label, three-arm, phase 2\/3 trial.\". ESMO Congress 2023; 2023.","DOI":"10.1016\/j.annonc.2023.09.2565"},{"issue":"13","key":"10.1016\/j.ejca.2025.116189_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7447","article-title":"Examining external control arms in oncology: a scoping review of applications to date","volume":"13","author":"Farah","year":"2024","journal-title":"Cancer Med"},{"issue":"11","key":"10.1016\/j.ejca.2025.116189_bib37","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1038\/s41591-023-02578-z","article-title":"Rethinking placebos: embracing synthetic control arms in clinical trials for rare tumors","volume":"29","author":"Serrano","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2025.116189_bib38","article-title":"Development and external validation of a radiomics combined with clinical nomogram for preoperative prediction prognosis of resectable pancreatic ductal adenocarcinoma patients","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"issue":"1137","key":"10.1016\/j.ejca.2025.116189_bib39","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20220072","article-title":"Pancreatic cancer, radiomics and artificial intelligence","volume":"95","author":"Marti-Bonmati","year":"2022","journal-title":"Br J Radio"},{"key":"10.1016\/j.ejca.2025.116189_bib40","unstructured":"Krebsregisterdaten) RK-IZf. Bauchspeicheldr\u00fcsenkrebs 2022 (Stand: 22.10.2024) [Available from: \u3008https:\/\/www.krebsdaten.de\/Krebs\/DE\/Content\/Krebsarten\/Bauchspeicheldruesenkrebs\/bauchspeicheldruesenkrebs_node.html\u3009."}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925010755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925010755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:46:16Z","timestamp":1781685976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804925010755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"alternative-id":["S0959804925010755"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2025.116189","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The basis for future personalized therapy approaches \u2013 Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pancreatic cancer patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2025.116189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116189"}}